84 results on '"Roberts, Lewis"'
Search Results
2. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
3. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis
4. A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection
5. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
6. AASLD guidelines for the treatment of hepatocellular carcinoma
7. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
8. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment
9. Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America
10. Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study
11. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States
12. A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice
13. Metformin Does Not Improve Survival of Cholangiocarcinoma Patients With Diabetes
14. Circulating Tumor Cells Are Associated With Poor Overall Survival in Patients With Cholangiocarcinoma
15. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
16. Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis
17. The Role of Hepatic Resection in the Treatment of Hepatocellular Cancer
18. Ectopic Gallbladder
19. Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation
20. Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma
21. Update on Biomarkers of Hepatocellular Carcinoma
22. Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors
23. Rethinking cancer immunotherapy: Using advanced cancer genetics in immune-mediated eradication of gastrointestinal cancers
24. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
25. Preclinical evidence of a novel anti-tumor effect of met-formin in cholangiocarcinoma (CCA): 38
26. Children with Chronic Hepatitis B in the United States and Canada
27. Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
28. Treating Hepatitis C in Lower-Income Countries
29. Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: In vitro and in vivo study
30. Fibroblast growth factor signaling in liver carcinogenesis
31. Chemopreventive strategies in hepatocellular carcinoma
32. Primary sclerosing cholangitis with equivocal cytology: Fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy
33. Analyzing risk factors for intrahepatic cholangiocarcinoma
34. Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
35. Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas
36. Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC BRIDGE Study: Global Comparison of Outcomes by Locoregional Therapy: 1940
37. Brivanib attenuates hepatic fibrosis in vivo and stellate cell proliferation in vitro by inhibition of FGF and VEGF signaling: 1234
38. PI3K/AKT Pathway Mediates Molecular Thermal Resistance in Hepatocellular Carcinoma: 879
39. Sulfatase 2 enhances hepatocellular carcinoma cell migration and invasion through activation of integrin α3β1 signaling: 865
40. Re-Examination of Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis: 621
41. Role of Hepatic Resection for Hepatocellular Carcinoma: Analysis of the HCC BRIDGE Study: 95
42. Model to estimate survival in ambulatory patients with hepatocellular carcinoma
43. Hepatocellular Carcinoma: Still in Search of Evidence-Based Care
44. Metabolic Syndrome and Alcohol Abuse: A Potential Hepatocarcinogenic Mix in Adolescents
45. miR-25 Targets TNF-Related Apoptosis Inducing Ligand (TRAIL) Death Receptor-4 and Promotes Apoptosis Resistance in Cholangiocarcinoma
46. Viral Hepatitis Among Somali Immigrants in Minnesota: Association of Hepatitis C With Hepatocellular Carcinoma
47. Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976–2008
48. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint
49. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma
50. Occult hepatitis B virus infection: Bit player or role player?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.